MedPath

Shock Wave Therapy for Lateral Hip Pain, Caused by Tendon Pathology

Not Applicable
Completed
Conditions
Tendinopathy
Registration Number
NCT03142971
Lead Sponsor
Fondazione IRCCS Policlinico San Matteo di Pavia
Brief Summary

The aim of this randomized controlled study is to investigate if focal shock wave is an effective treatment, with respect to hip pain and lower limb function, in a population affected by greater trochanteric pain syndrome with gluteal tendinopathy.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
50
Inclusion Criteria
  • duration of lateral hip pain of six weeks or longer,
  • normal passive hip range of movement (ROM),
  • sonographic evidence of gluteal tendinopathy at their insertional site at the greater trochanter
Exclusion Criteria
  • general contraindication to extracorporeal shock wave therapy (pacemaker, pregnancy, bleeding disorders or anticoagulant drug usage, cancer in the focal area),
  • history of rheumatologic disease,
  • previous fractures or surgery in the affected limb,
  • full thickness tear of the gluteal tendons,
  • osteoarthritis of the hip (with ROM limitation),
  • clinical signs of lumbar radiculopathy,
  • corticosteroid injections or other conservative therapies (except pharmacological pain treatments) since the onset of the current pain episode.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
LEFS scoreBaseline, at two months, at six months

Change from baseline LEFS (Lower extremity functional scale) total score at 2 months and at 6 months

p-NRSBaseline, at two months, at six months

Change from baseline p-NRS (pain-on-movement numeric rating scale) at 2 months and at 6 months.

Secondary Outcome Measures
NameTimeMethod

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.